AI or drug: which keeps weight off better in type 2 diabetes?
NCT ID NCT07555730
First seen May 01, 2026 · Last updated May 12, 2026 · Updated 3 times
Summary
This study tests whether an AI-guided lifestyle program can help adults with type 2 diabetes and overweight or obesity maintain weight loss as well as or better than continuing the drug tirzepatide. All 400 participants first receive tirzepatide for 20 weeks to lose weight, then are randomly assigned to either the AI lifestyle intervention or a lower dose of tirzepatide for another 52 weeks. The goal is to find effective, long-term weight management strategies for people with type 2 diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WEIGHT LOSS MAINTENANCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.